InvestSMART

Arovella Therapeutics Limited (ASX: ALA) - Announcements

Current share price for ALA : $0.053 0.002 (3.92%)+

ASX company news and announcements for Arovella Therapeutics Limited (ALA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Arovella Therapeutics Limited (ALA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Arovella Therapeutics Limited (ALA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Arovella Therapeutics Limited (ALA)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$64 Complete tumour clearance in gastric cancer animal study 29 Oct 2026 8:36AM $0.051 $0.053 risen by 3.92%
$64 First Patient Dosed with ALA-101 27 Oct 2026 8:41AM $0.049 $0.053 risen by 8.16%
$64 Quarterly Activities/Appendix 4C Cash Flow Report 23 Oct 2026 8:27AM $0.049 $0.053 risen by 8.16%
$64 Arovella receives R&D tax rebate of $4.03 million 22 Oct 2026 8:43AM $0.051 $0.053 risen by 3.92%
$64 Second Clinical Batch Released for Immediate Patient Use 7 Oct 2026 8:57AM $0.047 $0.053 risen by 12.77%
$64 Cell and Gene Innovation Spotlight Presentation 6 Oct 2026 4:55PM $0.047 $0.053 risen by 12.77%
$64 Notice of Annual General Meeting/Proxy Form 5 Oct 2026 8:20AM $0.047 $0.053 risen by 12.77%
$64 The path to first patient dosing 1 Oct 2026 1:54PM $0.050 $0.053 risen by 6%
$64 2026 ESG Report 17 Sep 2026 8:56AM $0.059 $0.053 fallen by 10.17%
$64 Notification of 2026 AGM Date 9 Sep 2026 8:21AM $0.060 $0.053 fallen by 11.67%
$64 Clinical manufacturing batch released, first site activated 7 Sep 2026 9:00AM $0.061 $0.053 fallen by 13.11%
$64 Corporate Governance Statement 20 Aug 2026 11:31AM $0.064 $0.053 fallen by 17.19%
$64 Appendix 4G 20 Aug 2026 11:28AM $0.064 $0.053 fallen by 17.19%
$64 Appendix 4E and Annual Report 20 Aug 2026 11:27AM $0.064 $0.053 fallen by 17.19%
$64 Notification regarding unquoted securities - ALA 17 Aug 2026 11:59AM $0.061 $0.053 fallen by 13.11%
$64 Investor Webinar Presentation 12 Aug 2026 1:11PM $0.060 $0.053 fallen by 11.67%
$64 Investor Webinar Registration 11 Aug 2026 4:10PM $0.062 $0.053 fallen by 14.52%
$64 Quarterly Activities/Appendix 4C Cash Flow Report 27 Jul 2026 12:15PM $0.065 $0.053 fallen by 18.46%
$64 Notice under Section 708A 30 Jun 2026 9:12AM $0.063 $0.053 fallen by 15.87%
$64 Notification of cessation of securities - ALA 30 Jun 2026 9:08AM $0.063 $0.053 fallen by 15.87%
$64 Application for quotation of securities - ALA 30 Jun 2026 9:06AM $0.063 $0.053 fallen by 15.87%
$64 First-In-Human Trial 25 Jun 2026 8:19AM $0.068 $0.053 fallen by 22.06%
$64 Change of Director's Interest Notice 10 Jun 2026 9:09AM $0.067 $0.053 fallen by 20.90%
$64 Turtle to Clinical Advisory Board&Fiorenza Lead Investigator 9 Jun 2026 2:01PM $0.067 $0.053 fallen by 20.90%
$64 Notification of cessation of securities - ALA 26 May 2026 9:26AM $0.075 $0.053 fallen by 29.33%

1 - 25 of 648 results

Page 1 of 26

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.